Differing natural killer cell, T cell and antibody profiles in antiretroviral-naive HIV-1 viraemic controllers with and without protective HLA alleles.

Previous work suggests that HIV controllers with protective human leukocyte antigen class I alleles (VC+) possess a high breadth of Gag-specific CD8+ T cell responses, while controllers without protective alleles (VC-) have a different unknown mechanism of control. We aimed to gain further insight i...

Full description

Bibliographic Details
Main Authors: Ana Moyano, Bongiwe Ndlovu, Msizi Mbele, Kewreshini Naidoo, Nasreen Khan, Jaclyn K Mann, Thumbi Ndung'u
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0286507
_version_ 1827931711147606016
author Ana Moyano
Bongiwe Ndlovu
Msizi Mbele
Kewreshini Naidoo
Nasreen Khan
Jaclyn K Mann
Thumbi Ndung'u
author_facet Ana Moyano
Bongiwe Ndlovu
Msizi Mbele
Kewreshini Naidoo
Nasreen Khan
Jaclyn K Mann
Thumbi Ndung'u
author_sort Ana Moyano
collection DOAJ
description Previous work suggests that HIV controllers with protective human leukocyte antigen class I alleles (VC+) possess a high breadth of Gag-specific CD8+ T cell responses, while controllers without protective alleles (VC-) have a different unknown mechanism of control. We aimed to gain further insight into potential mechanisms of control in VC+ and VC-. We studied 15 VC+, 12 VC- and 4 healthy uninfected individuals (UI). CD8+ T cell responses were measured by ELISpot. Flow cytometry was performed to analyse surface markers for activation, maturation, and exhaustion on natural killer (NK) cell and T cells, as well as cytokine secretion from stimulated NK cells. We measured plasma neutralization activity against a panel of 18 Env-pseudotyped viruses using the TZM-bl neutralization assay. We found no significant differences in the magnitude and breadth of CD8+ T cell responses between VC+ and VC-. However, NK cells from VC- had higher levels of activation markers (HLA-DR and CD38) (p = 0.03), and lower cytokine expression (MIP-1β and TNF-α) (p = 0.05 and p = 0.04, respectively) than NK cells from VC+. T cells from VC- had higher levels of activation (CD38 and HLA-DR co-expression) (p = 0.05), as well as a trend towards higher expression of the terminal differentiation marker CD57 (p = 0.09) when compared to VC+. There was no difference in overall neutralization breadth between VC+ and VC- groups, although there was a trend for higher neutralization potency in the VC- group (p = 0.09). Altogether, these results suggest that VC- have a more activated NK cell profile with lower cytokine expression, and a more terminally differentiated and activated T cell profile than VC+. VC- also showed a trend of more potent neutralizing antibody responses that may enhance viral clearance. Further studies are required to understand how these NK, T cell and antibody profiles may contribute to differing mechanisms of control in VC+ and VC-.
first_indexed 2024-03-13T06:56:32Z
format Article
id doaj.art-1036a0e035574194998ef71454b4da01
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-03-13T06:56:32Z
publishDate 2023-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-1036a0e035574194998ef71454b4da012023-06-07T05:31:58ZengPublic Library of Science (PLoS)PLoS ONE1932-62032023-01-01186e028650710.1371/journal.pone.0286507Differing natural killer cell, T cell and antibody profiles in antiretroviral-naive HIV-1 viraemic controllers with and without protective HLA alleles.Ana MoyanoBongiwe NdlovuMsizi MbeleKewreshini NaidooNasreen KhanJaclyn K MannThumbi Ndung'uPrevious work suggests that HIV controllers with protective human leukocyte antigen class I alleles (VC+) possess a high breadth of Gag-specific CD8+ T cell responses, while controllers without protective alleles (VC-) have a different unknown mechanism of control. We aimed to gain further insight into potential mechanisms of control in VC+ and VC-. We studied 15 VC+, 12 VC- and 4 healthy uninfected individuals (UI). CD8+ T cell responses were measured by ELISpot. Flow cytometry was performed to analyse surface markers for activation, maturation, and exhaustion on natural killer (NK) cell and T cells, as well as cytokine secretion from stimulated NK cells. We measured plasma neutralization activity against a panel of 18 Env-pseudotyped viruses using the TZM-bl neutralization assay. We found no significant differences in the magnitude and breadth of CD8+ T cell responses between VC+ and VC-. However, NK cells from VC- had higher levels of activation markers (HLA-DR and CD38) (p = 0.03), and lower cytokine expression (MIP-1β and TNF-α) (p = 0.05 and p = 0.04, respectively) than NK cells from VC+. T cells from VC- had higher levels of activation (CD38 and HLA-DR co-expression) (p = 0.05), as well as a trend towards higher expression of the terminal differentiation marker CD57 (p = 0.09) when compared to VC+. There was no difference in overall neutralization breadth between VC+ and VC- groups, although there was a trend for higher neutralization potency in the VC- group (p = 0.09). Altogether, these results suggest that VC- have a more activated NK cell profile with lower cytokine expression, and a more terminally differentiated and activated T cell profile than VC+. VC- also showed a trend of more potent neutralizing antibody responses that may enhance viral clearance. Further studies are required to understand how these NK, T cell and antibody profiles may contribute to differing mechanisms of control in VC+ and VC-.https://doi.org/10.1371/journal.pone.0286507
spellingShingle Ana Moyano
Bongiwe Ndlovu
Msizi Mbele
Kewreshini Naidoo
Nasreen Khan
Jaclyn K Mann
Thumbi Ndung'u
Differing natural killer cell, T cell and antibody profiles in antiretroviral-naive HIV-1 viraemic controllers with and without protective HLA alleles.
PLoS ONE
title Differing natural killer cell, T cell and antibody profiles in antiretroviral-naive HIV-1 viraemic controllers with and without protective HLA alleles.
title_full Differing natural killer cell, T cell and antibody profiles in antiretroviral-naive HIV-1 viraemic controllers with and without protective HLA alleles.
title_fullStr Differing natural killer cell, T cell and antibody profiles in antiretroviral-naive HIV-1 viraemic controllers with and without protective HLA alleles.
title_full_unstemmed Differing natural killer cell, T cell and antibody profiles in antiretroviral-naive HIV-1 viraemic controllers with and without protective HLA alleles.
title_short Differing natural killer cell, T cell and antibody profiles in antiretroviral-naive HIV-1 viraemic controllers with and without protective HLA alleles.
title_sort differing natural killer cell t cell and antibody profiles in antiretroviral naive hiv 1 viraemic controllers with and without protective hla alleles
url https://doi.org/10.1371/journal.pone.0286507
work_keys_str_mv AT anamoyano differingnaturalkillercelltcellandantibodyprofilesinantiretroviralnaivehiv1viraemiccontrollerswithandwithoutprotectivehlaalleles
AT bongiwendlovu differingnaturalkillercelltcellandantibodyprofilesinantiretroviralnaivehiv1viraemiccontrollerswithandwithoutprotectivehlaalleles
AT msizimbele differingnaturalkillercelltcellandantibodyprofilesinantiretroviralnaivehiv1viraemiccontrollerswithandwithoutprotectivehlaalleles
AT kewreshininaidoo differingnaturalkillercelltcellandantibodyprofilesinantiretroviralnaivehiv1viraemiccontrollerswithandwithoutprotectivehlaalleles
AT nasreenkhan differingnaturalkillercelltcellandantibodyprofilesinantiretroviralnaivehiv1viraemiccontrollerswithandwithoutprotectivehlaalleles
AT jaclynkmann differingnaturalkillercelltcellandantibodyprofilesinantiretroviralnaivehiv1viraemiccontrollerswithandwithoutprotectivehlaalleles
AT thumbindungu differingnaturalkillercelltcellandantibodyprofilesinantiretroviralnaivehiv1viraemiccontrollerswithandwithoutprotectivehlaalleles